Executive Vice President
MD, PhD in Protein Biochemistry and Immunology with over 25 years of experience in pharmaceutical biotechnology and translational medicine/research. He was a postdoc in biotechnology and cell therapy at the University of São Paulo and a research fellow at the Diabetes Research Institute, USA.
Thiago currently is the Executive Vice President at Bionovis, a biopharmaceutical company focused in developing, manufacturing and marketing highly complex therapeutic biologics. At Bionovis has been responsible for technology transfer partnerships with Janssen, Merck, Samsung Bioepis, Sandoz/Novartis and Fresenius Kabi, involving innovative biologics and several biosimilars.
In addition to his role at Bionovis, Thiago is an invited professor at the Faculty of Medicine of Santa Casa de São Paulo, CEPIC and an associate researcher at Instituto Butantan.
Register for the Biosimilars LatAm – Brazil 2023
Register for the Biosimilars LatAm – Europe 2023